Petauri, a leading purpose-built pharmaceutical services platform, announces the acquisition of four US-based firms: Bluprint Oncology, Cogency, Verascity, and Blendworks, from the Brightly Network. The combined businesses, founded in 2016 by Jan Hannon, Lisa Hefner, and Mark Ellis, PhD, comprise a comprehensive suite of medical communications agencies that specialize in oncology, hematology, and rare diseases across medical and commercial strategy, engagement, and education. The announcement marks another milestone in Petauri’s growth trajectory as the platform now numbers more than 360 professionals worldwide, all dedicated to the vision of improving patient outcomes by speeding access to life-changing medical breakthroughs.
Read the full article: Petauri™ Acquires Medical Communications Agencies in Major Expansion //
Source: https://www.prnewswire.com/news-releases/petauri-acquires-medical-communications-agencies-in-major-expansion-302221693.html